Skip to content
Dabour HubLEARN · PRACTICE · EXPLORESign inStudent

11.2.210-11 · Infectious Disease and Immunity

Making Monoclonal Antibodies — Cambridge AS & A Level Biology 9700 Revision Notes & Topical Questions

5 min read 11 parts Lesson 16 of 21 1 quiz

🩺
100% Curriculum Specification Match Lesson Doctor Verified
The only platform with 100% curriculum specification match and verified interactive question banks.
0%read
Lesson summary

11.2.2 Making Monoclonal Antibodies — CAMBRIDGE AS & A LEVEL BIOLOGY 9700 — REVISION NOTES notes: Describe how monoclonal antibodies are produced from hybridoma cells and evaluate the technique.Polyclonal — when an animal is infected or immunised, many B cell clones respond becau…

  • Plasma cells
  • Myeloma cells
  • Immunisation
  • Purification
  • Bioreactors
  • Conditions

Part 1 of 9Monoclonal and polyclonal antibodies

Polyclonal
  • Polyclonal when an animal is infected or immunised, many B cell clones respond because the antigen has several epitopes,
    • giving a mixture of antibodies.
Monoclonal
  • Monoclonal a population of identical antibodies made by a single clone of plasma cells, all binding the same epitope.
Value
  • Value this uniform specificity makes them very useful in medicine and research.

Part 2 of 9The problem solved by hybridomas

Plasma cells
  • Plasma cells they do not survive long in culture.
Myeloma cells
  • Myeloma cells cancerous B cells divide indefinitely but do not make useful antibody.
Solution
  • Solution the technique combines both properties.

Part 3 of 9Cell properties

CellProperty
B lymphocyte (plasma cell)Makes one specific antibody but divides only a limited number of times in culture
Myeloma cellDivides rapidly and indefinitely but does not make the required antibody
HybridomaMakes the specific antibody and divides indefinitely

Part 4 of 9Production steps

1
Immunisation
  • Immunisation inject a mouse with the antigen so its B cells make plasma cells.
    • (for example a protein from a cancer cell or pathogen)
2
Isolation
  • Isolation remove the spleen and collect B lymphocytes (plasma cells).
3
Fusion
  • Fusion fuse the B cells with myeloma (tumour) cells using polyethylene glycol or an electric pulse to make hybridoma cells.
4
Selection
  • Selection grow the mixture in a selective medium in which unfused myeloma cells and unfused B cells die.
5
Screening
  • Screening separate hybridomas into individual wells and test the culture fluid of each for antibody that binds the antigen.
6
Cloning
  • Cloning select a hybridoma making the correct antibody and grow it in large fermenters (or in mice).
7
Purification
  • Purification harvest the antibody and purify it from the culture fluid.

Part 5 of 9Large-scale production

Bioreactors
  • Bioreactors hybridomas grow under sterile conditions and antibody is secreted into the medium, so it can be collected continuously.
Purification
  • Purification affinity chromatography passes the medium through a column carrying the antigen or an antibody-binding protein.
  • Only antibodies of the required specificity remain and are later released.
Conditions
  • Conditions a supply of nutrients and oxygen, a constant temperature (about 37 °C) and pH, and removal of waste.
Quality control
  • Quality control each batch is tested to confirm that it binds only its target, and is pure and uncontaminated.

Part 6 of 9Why the antibodies are identical

Clone
  • Clone all antibodies come from one clone, so they are genetically identical and bind exactly one epitope.
Mitosis
  • Mitosis hybridomas divide by mitosis to give identical cells.
Cell roles
  • B cells give specificity, myeloma cells give immortality, and the selective medium removes cells lacking both properties.

Part 7 of 9Humanised antibodies

Mouse antibodies
  • Mouse antibodies they can cause an immune reaction in humans because they are recognised as foreign.
Humanised antibodies
  • Humanised antibodies a mouse variable region is joined to a human constant region.
Fully human antibodies
  • Fully human antibodies now produced by newer techniques.
Benefit
  • Benefit they are safer and last longer in patients.

Part 8 of 9Evaluation

Advantages
  • Advantages very high specificity, a constant supply of identical antibody and the ability to target any antigen.
Disadvantages
  • Disadvantages the technique is complex and expensive, uses animals and may cause side effects or immune reaction.
    • (ethical concerns)
Maintenance
  • Maintenance the tumour-derived hybridoma line must be maintained carefully.

Part 9 of 9More from the specification

1Monoclonal antibody binding of toxins
  • Monoclonal antibody binding of toxins hybridoma clones synthesize monospecific monoclonal antibodies engineered to bind and neutralize lethal bacterial toxins.
2Active vs Passive Immunity
  • Active immunity develops when a person is exposed to foreign antigens on pathogen surfaces, stimulating clonal selection of B-cells and production of memory cells,
  • whereas passive immunity provides rapid, short-term resistance through direct transfer of external antibodies into blood.
3Vaccines and Immunological Memory
  • Vaccines introduce attenuated pathogens, toxoids,
  • or isolated surface antigens, triggering a primary immune response and establishing long-lived memory B and T cells that protect against infectious disease.
4Monoclonal Antibody Production Method
  • Monoclonal antibodies are produced by fusing isolated antigen-sensitised spleen B-lymphocytes with immortal myeloma cells to form hybridomas,
  • which are screened and cultured to yield identical antibodies.
5Diagnostic and Therapeutic Targeting
  • Because monoclonal antibodies bind with high specificity to a single unique epitope on a cell surface or circulating toxin, they are utilized to identify pathogen types, detect hCG in urine,
  • and deliver targeted cancer treatments.
6Receptor protein
  • Protein on the postsynaptic membrane that binds neurotransmitter.
7Vaccine
  • Harmless antigen preparation that induces memory cells.
8Vaccination
  • Introducing a weakened pathogen's antigens to produce memory cells.
9Disease
  • A condition in which part of the body does not function properly.
10Toxin
  • A poison released by bacteria.
11Active immunity
  • Immunity from making your own antibodies and memory cells.
12Passive immunity
  • Short-term immunity from antibodies given by another individual.
13Memory cell
  • A lymphocyte that keeps instructions for making a specific antibody.
14Secondary response
  • The rapid, large response on re-exposure to an antigen.

Key terms

TermMeaning
Monoclonal antibodyIdentical antibodies from one clone, all binding the same epitope.
Polyclonal antibodiesA mixture of antibodies from many B cell clones.
HybridomaA fused plasma cell and myeloma cell that divides indefinitely and makes one antibody.
Myeloma cellA cancerous B cell that divides indefinitely.
Selective mediumA culture medium in which only the wanted cells survive.
Humanised antibodyA mouse antibody modified to carry human constant regions.

Avoid these mistakes

1
Saying plasma cells divide indefinitely in culture — they divide only a limited number of times.
2
Saying monoclonal antibodies come from many clones — they come from a single clone.
3
Saying unfused cells survive in the selective medium — they die.
4
Saying mouse antibodies are always safe in humans — they can cause an immune reaction.

Last updated: